Zobrazeno 1 - 10
of 81
pro vyhledávání: '"F J, Bemelman"'
Autor:
P. Bouwmans, A. L. Messchendorp, J. S. Sanders, L. Hilbrands, M. E. J. Reinders, P. Vart, F. J. Bemelman, A. C. Abrahams, M. A. van den Dorpel, M. A. Ten Dam, A. P. J. de Vries, T. Rispens, M. Steenhuis, R. T. Gansevoort, M. H. Hemmelder, RECOVAC Collaborators
Publikováno v:
BMC Nephrology, Vol 23, Iss 1, Pp 1-10 (2022)
Abstract Background COVID-19 is associated with increased morbidity and mortality in patients with chronic kidney disease (CKD) stages G4-G5, on dialysis or after kidney transplantation (kidney replacement therapy, KRT). SARS-CoV-2 vaccine trials do
Externí odkaz:
https://doaj.org/article/db49c9e3f51e4744ab4bb295e6b08127
Autor:
S. E. de Boer, J. S.F. Sanders, F. J. Bemelman, M. G.H. Betjes, J. G.M. Burgerhof, L. Hilbrands, D. Kuypers, B. C. van Munster, S. A. Nurmohamed, A. P.J. de Vries, A. D. van Zuilen, D. A. Hesselink, S. P. Berger
Publikováno v:
BMC Nephrology, Vol 22, Iss 1, Pp 1-10 (2021)
Abstract Background In 2019, more than 30 % of all newly transplanted kidney transplant recipients in The Netherlands were above 65 years of age. Elderly patients are less prone to rejection, and death censored graft loss is less frequent compared to
Externí odkaz:
https://doaj.org/article/01bc2a273ab84de0bc1322baa18d8dce
Autor:
Dennis A. Hesselink, A. P. J. de Vries, B. C. van Munster, L. Hilbrands, Johannes G. M. Burgerhof, Shaikh A. Nurmohamed, Michiel G. H. Betjes, S E de Boer, Jan-Stephan F. Sanders, A D van Zuilen, F. J. Bemelman, Stefan P Berger, Dirk Kuypers
Publikováno v:
BMC Nephrology, 22(1):208. BioMed Central Ltd.
Bmc nephrology, 22(1):208. BMC
BMC Nephrology, 22, 1
de Boer, S E, Sanders, J S F, Bemelman, F J, Betjes, M G H, Burgerhof, J G M, Hilbrands, L, Kuypers, D, van Munster, B C, Nurmohamed, S A, de Vries, A P J, van Zuilen, A D, Hesselink, D A & Berger, S P 2021, ' Rationale and design of the OPTIMIZE trial : OPen label multicenter randomized trial comparing standard IMmunosuppression with tacrolimus and mycophenolate mofetil with a low exposure tacrolimus regimen In combination with everolimus in de novo renal transplantation in Elderly patients ', BMC Nephrology, vol. 22, no. 1, pp. 208 . https://doi.org/10.1186/s12882-021-02409-8
BMC Nephrology
BMC nephrology, 22(1):208. BioMed Central
BMC Nephrology, 22
BMC Nephrology, 22(1). BMC
BMC Nephrology, Vol 22, Iss 1, Pp 1-10 (2021)
BMC Nephrology, 22(1). BioMed Central
Bmc nephrology, 22(1):208. BMC
BMC Nephrology, 22, 1
de Boer, S E, Sanders, J S F, Bemelman, F J, Betjes, M G H, Burgerhof, J G M, Hilbrands, L, Kuypers, D, van Munster, B C, Nurmohamed, S A, de Vries, A P J, van Zuilen, A D, Hesselink, D A & Berger, S P 2021, ' Rationale and design of the OPTIMIZE trial : OPen label multicenter randomized trial comparing standard IMmunosuppression with tacrolimus and mycophenolate mofetil with a low exposure tacrolimus regimen In combination with everolimus in de novo renal transplantation in Elderly patients ', BMC Nephrology, vol. 22, no. 1, pp. 208 . https://doi.org/10.1186/s12882-021-02409-8
BMC Nephrology
BMC nephrology, 22(1):208. BioMed Central
BMC Nephrology, 22
BMC Nephrology, 22(1). BMC
BMC Nephrology, Vol 22, Iss 1, Pp 1-10 (2021)
BMC Nephrology, 22(1). BioMed Central
Background In 2019, more than 30 % of all newly transplanted kidney transplant recipients in The Netherlands were above 65 years of age. Elderly patients are less prone to rejection, and death censored graft loss is less frequent compared to younger
Autor:
P L Klarenbeek, E B M Remmerswaal, I J M ten Berge, M E Doorenspleet, B D C van Schaik, R E E Esveldt, S D Koch, A ten Brinke, A H C van Kampen, F J Bemelman, P P Tak, F Baas, N de Vries, R A W van Lier
Publikováno v:
PLoS Pathogens, Vol 8, Iss 9, p e1002889 (2012)
CD8(+) T-cell responses against latent viruses can cover considerable portions of the CD8(+) T-cell compartment for many decades, yet their initiation and maintenance remains poorly characterized in humans. A key question is whether the clonal repert
Externí odkaz:
https://doaj.org/article/3f27ee0b192941a0aa0ab093275426df
Autor:
J A M Hagenaars, Julia H E Houtzager, Martin B A Heemskerk, J J Homan van der Heide, Hessel Peters-Sengers, F. J. Bemelman, R W Klaasen, S E Joor, P M Rebers, Joke I. Roodnat, Robert C. Minnee, Mirza M. Idu
Publikováno v:
American Journal of Transplantation, 18(8), 1966-1976. Wiley-Blackwell Publishing Ltd
American journal of transplantation, 18(8), 1966-1976. Wiley-Blackwell
American journal of transplantation, 18(8), 1966-1976. Wiley-Blackwell
Insufficient hemodynamics during agonal phase-i.e. the period between withdrawal of life-sustaining treatment and circulatory arrest-in Maastricht category III circulatory-death donors (DCD) potentially exacerbate ischemia/reperfusion injury. We incl
Publikováno v:
Urology Annals, Vol 5, Iss 1, Pp 45-46 (2013)
We describe a case-report of a chylous ascites after laparoscopic donor nephrectomy, summarize the current literature, and hypothesize on the etiology of this complication.
Externí odkaz:
https://doaj.org/article/19d8bc98a1a5487bbd9ab0414abfade5
Autor:
A. P. J. de Vries, J. J. Homan van der Heide, J. Lardy, J. S. Sanders, J. W. de Fijter, Christina Krikke, M. van Dijk, C. Meyer, Dirk Jan A. R. Moes, I. J. M. ten Berge, Mirza M. Idu, Dave L. Roelen, Stefan P Berger, Marlies E.J. Reinders, Jan Ringers, Jesper Kers, F. J. Bemelman, A. H. Zwinderman, Ingeborg M. Bajema, Hessel Peters-Sengers, K. A. M. I. van Donselaar-van der Pant, EF de Maar, Sandrine Florquin
Publikováno v:
American Journal of Transplantation, 17(4), 1020-1030. Wiley
American Journal of Transplantation, 17(4), 1020-1030
American Journal of Transplantation
American journal of transplantation, 17(4), 1020-1030. Wiley-Blackwell
American Journal of Transplantation, 17(4), 1020-1030
American Journal of Transplantation
American journal of transplantation, 17(4), 1020-1030. Wiley-Blackwell
In renal transplantation, use of calcineurin inhibitors (CNIs) is associated with nephrotoxicity and immunosuppression with malignancies and infections. This trial aimed to minimize CNI exposure and total immunosuppression while maintaining efficacy.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa6cb8bcf2ec0af07857158a04deb5dc
https://research.rug.nl/en/publications/bbb2b992-b003-4ab7-9c5e-bf02baa96894
https://research.rug.nl/en/publications/bbb2b992-b003-4ab7-9c5e-bf02baa96894
Autor:
L. Berthelot, T. Robert, T. Tabary, V. Vuiblet, M. Drame, O. Toupance, P. Rieu, R. C. Monteiro, F. Toure, S. Ferrario, V. Cantaluppi, M. De Lena, S. Dellepiane, S. Beltramo, M. Rossetti, A. M. Manzione, M. Messina, M. Gai, C. Dolla, L. Biancone, G. Camussi, P. Pontrelli, A. R. Oranger, M. Accetturo, F. Rascio, M. Gigante, G. Castellano, A. Schena, M. Fiorentino, A. Zito, G. Zaza, G. Stallone, L. Gesualdo, G. Grandaliano, E. F. Pattonieri, M. Gregorini, V. Corradetti, C. Rocca, S. Milanesi, A. Peloso, J. Ferrario, M. Cannone, F. Bosio, N. Maggi, M. A. Avanzini, P. Minutillo, M. Paulli, M. Maestri, T. Rampino, A. Dal Canton, K. S. T. Wu, O. Coxall, Y. Luque, S. Candon, M. Rabant, L.-H. Noel, E. Thervet, L. Chatenoud, R. Snanoudj, D. Anglicheau, C. Legendre, J. Zuber, P. Hruba, I. Brabcova, E. Krepsova, J. Slatinska, A. Sekerkova, I. Striz, R. Zachoval, O. Viklicky, T. M. Scholbach, H.-K. Wang, C.-C. Loong, A.-H. Yang, T.-H. Wu, H. Guberina, V. Rebmann, P. Dziallas, S. Dolff, J. Wohlschlaeger, F. M. Heinemann, O. Witzke, Y. M. Zoet, F. H. J. Claas, P. A. Horn, A. Kribben, I. I. N. Doxiadis, N. Prasad, B. Yadav, V. Agarwal, A. Jaiswal, M. Rai, C. M. Hope, P. T. Coates, P. S. Heeger, R. Carroll, V. Masola, M. F. Secchi, M. Onisto, G. Gambaro, A. Lupo, M. Matsuyama, T. Kobayashi, Y. Yoneda, J. Chargui, J. L. Touraine, R. Yoshimura, D. Vizza, A. Perri, S. Lupinacci, G. Toteda, D. Lofaro, F. Leone, P. Gigliotti, A. La Russa, T. Papalia, R. Bonofilgio, A. Sentis Fuster, J. Kers, U. Yapici, N. Claessen, F. J. Bemelman, I. J. M. Ten Berge, S. Florquin, D. Glotz, L. Rostaing, J.-P. Squifflet, P. Merville, C. Belmokhtar, G. Le Ny, Y. Lebranchu, D. A. Papazova, M. Friederich-Persson, M. P. Koeners, J. A. Joles, M. C. Verhaar, H. L. Trivedi, A. V. Vanikar, S. D. Dave, B. Suarez Alvarez, S. Garcia Melendreras, R. Carvajal Palao, C. Diaz Corte, M. Ruiz Ortega, C. Lopez-Larrea, A. K. Yadav, D. Bansal, V. Kumar, M. Minz, V. Jha, D. Kaminska, K. Koscielska-Kasprzak, P. Chudoba, O. Mazanowska, M. Banasik, M. Zabinska, M. Boratynska, A. Lepiesza, K. Korta, M. Klinger, R. Csohany, A. Prokai, D. Pap, N. Balicza-Himer, A. Vannay, A. Fekete, K. Kis-Petik, J. Peti-Peterdi, A. Szabo, A. Masajtis-Zagajewska, K. Muras, M. Niewodniczy, M. Nowicki, J. Pascual, T. R. Srinivas, S. Chadban, F. Citterio, M. Henry, F. Oppenheimer, P.-C. Lee, H. Tedesco-Silva, M. Zeier, Y. Watarai, G. Dong, M. Hexham, P. Bernhardt, F. Vincenti, M. T. Rocchetti, J. Su owicz, A. Wojas-Pelc, E. Ignacak, K. Janda, M. Krzanowski, W. Su owicz, M. Mitsuhashi, T. Murakami, A. Benso, D. Leuning, M. Reinders, E. Lievers, J. Duijs, A. J. Van Zonneveld, C. Van Kooten, M. Engelse, T. Rabelink, A. Assounga, S. Omarjee, Z. Ngema, A. Ersoy, A. Gultepe, E. Isiktas Sayilar, H. Akalin, F. Coskun, M. Oner Torlak, Y. Ayar, M. Riegersperger, M. Plischke, C. Steinhauser, A. Jallitsch-Halper, G. Sengoelge, W. C. Winkelmayer, G. Sunder-Plassmann, M. Foedinger, M. Kaziuk, M. Kuz'Niewski, A. B Tkowska- Prokop, K. Pa Ka, P. Dumnicka, W. Kolber, W. Su Owicz
Publikováno v:
Nephrology Dialysis Transplantation. 29:iii528-iii538
Publikováno v:
Clinical microbiology and infection. 20(11):1119-1125
This review gives an outline of the indications for faecal microbiota transplantation (FMT) for diseases other than Clostridium difficile (C. difficile) infection. The remarkable efficacy of FMT against C. difficile infection has already been demonst
Autor:
Luuk B. Hilbrands, E.M. van Duijnhoven, Frans H.J. Claas, Azam S. Nurmohamed, Jan-Stephan F. Sanders, Michiel L. Bots, M. A. Seelen, Maarten H. L. Christiaans, Wendy Swelsen, I. J. M. ten Berge, F. J. van Ittersum, A. F. G. van der Meer, Marije C. Baas, N. C. van der Weerd, Caroline Roozendaal, Henderikus G. Otten, Annechien J. A. Lambeck, Joris Vanderlocht, Marcel G.J. Tilanus, Andries J. Hoitsma, D.L. Roelen, Michiel G. H. Betjes, F. J. Bemelman, Bouke G. Hepkema, J.W. de Fijter, Eric Spierings, N M Lardy, Wil A. Allebes, Irma Joosten, Marianne C. Verhaar, M. Gelens, Lotte Wieten, Laura Bungener, A D van Zuilen, Christien Voorter, F. van Reekum, K. A. M. I. van Donselaar-van der Pant, Cornelis E. Hack
Publikováno v:
Transplant Immunology, 31, 4, pp. 184-90
Transplant immunology, 31(4), 184-190. Elsevier
Transplant Immunology, 31(4), 184-190. Elsevier
Transplant Immunology, 31(4), 184-190
Otten, H G, Joosten, I, Allebes, W A, van der Meer, A, Hilbrands, L B, Baas, M, Spierings, E, Hack, C E, van Reekum, F, van Zuilen, A D, Verhaar, M C, Bots, M L, Seelen, M A J, Sanders, J S F, Hepkema, B G, Lambeck, A J, Bungener, L B, Roozendaal, C, Tilanus, M G J, Vanderlocht, J, Voorter, C E, Wieten, L, van Duijnhoven, E, Gelens, M, Christiaans, M, van Ittersum, F J, Nurmohamed, S A, Lardy, N M, Swelsen, W T, van Donselaar-v Pant, K A, van der Weerd, N C, ten Berge, I J M, Bemelman, F J, Hoitsma, A J, de Fijter, J W, Betjes, M G H, Roelen, D L & Claas, F H J 2014, ' The PROCARE consortium: Toward an improved allocation strategy for kidney allografts ', Transplant Immunology, vol. 31, no. 4, pp. 184-190 . https://doi.org/10.1016/j.trim.2014.09.008
Transplant Immunology, 31, 184-90
Transplant immunology, 31(4), 184-190. Elsevier
Transplant Immunology, 31(4), 184-190. Elsevier
Transplant Immunology, 31(4), 184-190
Otten, H G, Joosten, I, Allebes, W A, van der Meer, A, Hilbrands, L B, Baas, M, Spierings, E, Hack, C E, van Reekum, F, van Zuilen, A D, Verhaar, M C, Bots, M L, Seelen, M A J, Sanders, J S F, Hepkema, B G, Lambeck, A J, Bungener, L B, Roozendaal, C, Tilanus, M G J, Vanderlocht, J, Voorter, C E, Wieten, L, van Duijnhoven, E, Gelens, M, Christiaans, M, van Ittersum, F J, Nurmohamed, S A, Lardy, N M, Swelsen, W T, van Donselaar-v Pant, K A, van der Weerd, N C, ten Berge, I J M, Bemelman, F J, Hoitsma, A J, de Fijter, J W, Betjes, M G H, Roelen, D L & Claas, F H J 2014, ' The PROCARE consortium: Toward an improved allocation strategy for kidney allografts ', Transplant Immunology, vol. 31, no. 4, pp. 184-190 . https://doi.org/10.1016/j.trim.2014.09.008
Transplant Immunology, 31, 184-90
Kidney transplantation is the best treatment option for patients with end-stage renal failure. At present, approximately 800 Dutch patients are registered on the active waiting list of Eurotransplant The waiting time in the Netherlands for a kidney f